AstraZeneca has unveiled plans for a new £330m global research and development centre and corporate headquarters at Cambridge Biomedical Campus, just two months after US rival Pfizer’s takeover attempt.
The new HQ will house AstraZeneca’s biologics research and protein
Thank you for reading EG
Want to read more? Enjoy a story a day for FREE for one month.
